NCT03653403View on ClinicalTrials.gov

Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With Control Gel

PHASE1CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

August 8, 2018

Primary Completion Date

June 19, 2019

Study Completion Date

June 19, 2019

Conditions
Acne Vulgaris
Interventions
DRUG

IDP-126 Gel

Component A

DRUG

Control Gel

gel

Trial Locations (1)

78759

Valeant Site 01, Austin

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT03653403 - Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With Control Gel | Biotech Hunter | Biotech Hunter